Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin

Abstract Antibody‐mediated graft rejection caused by donor‐specific antibodies (DSA‐MR) remains a serious problem after heart transplantation (HTx). IgM‐enriched human intravenous immunoglobulin (IGM‐IVIG) consists of 76% IgG, 12% IgM, and 12% IgA and provides a new multifactorial approach for DSA‐M...

Full description

Bibliographic Details
Main Authors: Moritz Benjamin Immohr, Payam Akhyari, Hug Aubin, Ralf Westenfeld, Arash Mehdiani, Raphael Romano Bruno, Nihat Firat Sipahi, Sophiko Erbel‐Khurtsidze, Petra Reinecke, Igor Tudorache, Artur Lichtenberg, Udo Boeken
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Heart transplantation
Antibody mediated rejection
Immunoglobulin
IgM
Donor specific antibody
Online Access:https://doi.org/10.1002/ehf2.13409

Internet

https://doi.org/10.1002/ehf2.13409

Similar Items